Mersana Therapeutics Inc (MRSN) — Capital Reinvestment Ratio
Latest as of September 2022:
0.01x
Mersana Therapeutics Inc (MRSN) has a Capital Reinvestment Ratio of 0.01x as of September 2022, meaning it reinvests 0% of its operating cash flow ($54.60 Million) in capital expenditures ($426.00K). See Mersana Therapeutics Inc (MRSN) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
$54.60 Million
USD
Capital Expenditures
$426.00K
USD
Data as of
Sep 2022
Most recent filing
Mersana Therapeutics Inc Capital Reinvestment Ratio (2016–2016)
This chart tracks Mersana Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Mersana Therapeutics Inc (2016–2016)
Year-by-year Capital Reinvestment Ratio for Mersana Therapeutics Inc from 2016 to 2016. For live market cap and broader valuation context, see Mersana Therapeutics Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.03x | $31.59 Million | $1.08 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow